| Document Date: 2001-01-10 06:50:51
Open Document File Size: 2,07 MBShare Result on Facebook
City Rockville / / Company Merck / The Preston Corporation / BIRCH POINT MEDICAL INC. / FDA’s / / Country United States / / IndustryTerm drug solution / lontophoresis preamendment iontophoresis devices / iontophoresis devices / preamendment devices / treatment of herpes / charged drug solution / centers devices / manufacturing filing / premarket device / final classification devices / low volt devices / iontophoresis delivery device / identification devices / / MedicalCondition scar / cervical and lower back pain / arthritis / tendonitis / herpes labialis / bursitis / treatment Raynaud’s disease / iontophoresis arthritis / neuritis / plantar warts / small molecule substance inflammatory lontophoresis The technology / injury / fibrositis / infection / cystic fibrosis / fungus infections / illness / dental hypersensitivity / fungal infections / / MedicalTreatment drug delivery system / Electrotherapy / physical therapy / / Organization School of Dental Medicine / Food and Drug Administration / Medical Association / US Federal Reserve / American Medical Association / SUNY / / Person Neil I. Spielholz / Danny D. Smith / Luther Kloth / / Position hearing clerk / / Product dexamethasone / sodium chloride / lidocaine / acetic acid / Pilocarpine hydrochloride / / ProgrammingLanguage DC / / Technology drug delivery / electrophoresis / drug delivery system / molecule substance inflammatory lontophoresis The technology / /
SocialTag |
December 14, 2000 Dockets Management Branch (HFA-305) Food and Drug Administration